Hypersensitivity, Immediate  >>  GSK870086 inhalation  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GSK870086 inhalation / GSK
NCT01381445: A Study Assessing GW870086's Potential to Cause Skin Thinning

Completed
1
20
Europe
GW870086 0.2%, GW870086 2%, Clobetasol Propionate, Placebo
GlaxoSmithKline
Dermatitis, Atopic
07/11
07/11

Download Options